-Hypercapnia is regularly observed in chronic lung disease, such as bronchopulmonary dysplasia in preterm infants. Hypercapnia results in increased nitric oxide synthase activity and in vitro formation of nitrates. Neural vasculature of the immature subject is particularly sensitive to nitrative stress. We investigated whether exposure to clinically relevant sustained high CO 2 causes microvascular degeneration in the newborn brain by inducing nitrative stress, and whether this microvascular degeneration has an impact on brain growth. Newborn rat pups were exposed to 10% CO2 as inspired gas (PaCO 2 ϭ 60 -70 mmHg) starting within 24 h of birth until postnatal day 7 (P7). Brains were notably collected at different time points to measure vascular density, determine brain cortical nitrite/nitrate, and trans-arachidonic acids (TAAs; products of nitration) levels as effectors of vessel damage. Chronic exposure of rat pups to high CO2 (PaCO 2 Ϸ 65 mmHg) induced a 20% loss in cerebrovascular density at P3 and a 15% decrease in brain mass at P7; at P30, brain mass remained lower in CO2-exposed animals. Within 24 h of exposure to CO2, brain eNOS expression and production of nitrite/nitrate doubled, lipid nitration products (TAAs) increased, and protein nitration (3-nitrotyrosine immunoreactivity) was also coincidently augmented on brain microvessels (lectin positive). Intracerebroventricular injection of TAAs (10 M) replicated cerebrovascular degeneration. Treatment of rat pups with NOS inhibitor (L-N -nitroarginine methyl ester) or a peroxynitrite decomposition catalyst (FeTPPS) prevented hypercapnia-induced microvascular degeneration and preserved brain mass. Cytotoxic effects of high CO2 were reproduced in vitro/ex vivo on cultured endothelial cells and sprouting microvessels. In summary, hypercapnia at values frequently observed in preterm infants with chronic lung disease results in increased nitrative stress, which leads to cerebral cortical microvascular degeneration and curtails brain growth. brain microvasculature; cell death; reactive nitrogen species; transfatty acids.
never been demonstrated. Additionally, newborn infants are regularly exposed to hypercapnia especially as a result of incurred chronic lung disease, such as bronchopulmonary dysplasia (BPD) (25) . BPD is itself associated with adverse long-term neurological and neurodevelopmental prognosis (33) . Although chronic hypercapnia has been suggested to exert lung protection during mechanical ventilation (5, 23, 36) , brain injury and neurodevelopmental disability may be complications (9, 37) . Increased tissue oxygenation in response to clinically relevant hypercapnia (Pa CO 2 Ϸ 60 -65 mmHg) may, in part, explain adverse consequences of hypercapnia (37) . On the other hand, direct cytotoxicity of hypercapnia to the retinal vasculature and possibly to the brain has been reported (13, 16) . Interestingly, in vitro CO 2 catalyzes the generation of nitrating products (3, 14) . Whether hypercapnia affects brain integrity in vivo by inducing nitration remains unknown. This aspect is especially relevant for the newborn neural vasculature, which is particularly susceptible to nitro-oxidative stress (34) , as exemplified by the retinovascular endothelial cell suceptibility to cytotoxic effects of the transarachidonic acids (TAA)-a family of nitrative stress-derived lipids, including the equipotent 5E-, 8E-, 11E-, and 14E-AA isomers-in a model of retinopathy of prematurity (17, 20) . We, therefore, investigated the effects of clinically relevant prolonged hypercapnia on the newborn brain, by focusing on its neural vasculature, and explored mechanisms implicated.
We, hereby, report that chronic exposure of newborn rat pups to hypercapnia (ϳ65 mmHg) leads to cerebrovascular nitrative stress associated with increased generation of TAAs, which exert cerebromicrovascular endothelial cytotoxicity and curtail brain growth; these hypercapnia-induced adverse effects were prevented by decreasing the nitrative stress.
MATERIALS AND METHODS
Animals. Sprague-Dawley rat pups (n ϭ 200; Charles River Laboratories) were used following approval of the research protocol by the Animal Care Committee of the Centre Hospitalier Universitaire Ste-Justine, in accordance with guidelines of the Canadian Council on Animal Care.
Within 24 h of birth, rat pups and their mothers were placed in a 10% CO 2, 21% O2, and 69% N2 environment (Oxycycler; Biospherix) up to postnatal day 7 (P7). Some animals were treated from P1 to P7 with intraperitoneal injections of a nitric oxide synthase inhibitor (L-N -nitroarginine methyl ester, L-NAME; 20 mg · kg Ϫ1 · day
Ϫ1
twice a day; Sigma-Aldrich), a peroxynitrite decomposition catalyst [5, 10, 15, 20 -tetrakis(4-sulfonatophenyl) porphyrinato iron (III), FeTPPS; 10 mg · kg Ϫ1 · day Ϫ1 twice a day; Calbiochem] or vehicle (0.9% NaCl). . A: representative lectin-stained cerebral sections. Rat pups were exposed from 24 h of birth to normocapnia (control) or hypercapnia (CO2) until 3 (P3) or 7 (P7) days postpartum. Scale bar ϭ 100 m. Values in histogram are expressed as means Ϯ SE of vessel density in cortical regions. n ϭ 6 per group. *P Ͻ 0.05 vs. respective age-matched control. B: brain cell DNA fragmentation from P3 rat pups assessed using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). Scale bar ϭ 100 m. Values in histogram are expressed as means Ϯ SE; n ϭ 5 per group. *P Ͻ 0.05 compared with control. C: time-dependent effect of hypercapnia on brain weight; n ϭ 6 -20 per group. *P Ͻ 0.05 vs. respective aged-control. D: time-dependent effect of hypercapnia on body weight; n ϭ 6 -20 per group.
Intracerebroventricular injections of TAAs. In separate sets of experiments, P7 rat pups were anesthetized with isoflurane (2%) and injected (stereotaxic coordinates of the left lateral ventricle: PA-1.0 mm, lateral-1.0 mm from bregma, and ventral-2.0 mm relative to dura) with vehicle (0.5% ethanol in saline) or 14E-AA (10 M) using a 10-l Hamilton syringe; 14E-AA was synthesized from corresponding epoxides, as previously described (22) . Animals were killed 24 h postinjection, and brains were processed for immunohistochemistry.
Endothelial cell viability assay. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assays were performed to assess cell viability as described previously (1) . Briefly, endothelial cells previously isolated from newborn pig brain (1, 20) were starved and cultured for 24 h in endothelial growth medium-2 (Clonetics) in 5% (control) or 10% (hypercapnic) CO 2 levels, by maintaining normal pH with NaHCO 3; endothelial cells of Յ5 passages were used. MTT (0.5 mg/ml) was then added and following a 3-h incubation, cells were solubilized in acidifed isopropanol (40 mM HCl). Optical density was measured at 560 nm with 690 nm as a reference readout. Cell viability was expressed as a percentage of optical density relative to control.
Aortic ring explants. The microvascular sprouting assay was performed as reported previously (20) . Aortic rings were cultured for 3 days in endothelial growth medium-2 (Clonetics) in 5% (control) or 10% (hypercapnic) CO 2 levels; pH was controlled with NaHCO3. Photomicrographs of individual explants were taken before and after completion of the treatment.
Brain explants. Brain cortex explants from rat pups (P3-P6) were cultured in vitro based on modifications from retinal explant protocols (6, 28) . Brains were sectioned in ice-cold culture medium using a Measurement of TAAs. Lipids were extracted from the brain cortex, separated by HPLC, and analyzed by isotopic dilution followed by GC/MS techniques, as previously described (39) . Since TAA seem to elicit comparable effects on neural vasculature (1, 20) , 14E-AA was measured as an indication of TAA levels.
Determination of nitrite/nitrate levels. Nitrite plus nitrate concentrations in the brain cortex were determined by means of a colorimetry-based assay using Griess reagents, as previously reported (24) .
Immunohistochemistry. Brain cryosections (20 m) were labeled overnight at 4°C with TRITC-conjugated endothelial cell marker lectin Griffonia simplicifolia (1:100; Sigma-Aldrich), alone or in combination with a monoclonal antibody against endothelial nitric oxide synthase (eNOS; 1:200; BD Biosciences) or a polyclonal antibody against 3-nitrotyrosine (3-NT; 1:200; Upstate/Millipore). Alexa-488-conjugated secondary antibody (1:200, Molecular Probes/Invitrogen) was applied for 60 min and DAPI (300 nM) for 2 min. Labeled sections were examined under an epifluorescent microscope (Eclipse E800; Nikon) equipped with a digital image analysis system (ACT-1 software; Nikon).
Measurement of cerebral cortex vascular density. Vascular density was quantified using the ImageJ 1.41 software (National Institutes of Health, Bethesda, MD) from pictures of brain sections labeled with the TRITC-conjugated lectin. Vascular density in the cortical area was expressed as a percentage of the cortical area. The use of this technical approach to measure vascular density has already been reported in the retina (2, 20) and the brain (34) .
Terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was performed on paraffin-embeded brain sections, as indicated by the manufacturer (Chemicon/Millipore).
Real-time PCR analysis. RNA from brain cortex samples was extracted using TRIzol (Invitrogen) and cDNA synthesized from 2 g of RNA. Quantitative real-time PCR was performed in a sequence detection system (MxPro 3000 QPCR Systems, Stratagene). All PCR reactions were performed in duplicate. Rat endothelial and inducible NOS primers were selected according to Kaur et al. (19) and beta- Fig. 3 . Effects of hypercapnia on cerebral cortex nitrite/nitrate concentrations (A), 14E-arachidonic acid (14E-AA) levels (B), and cerebral nitrative stress (C). A: brain cortex nitrite/nitrate levels; n ϭ 8 per group. *P Ͻ 0.05 compared with control. B: brain cortex 14E-AA levels extracted 6, 18, or 24 h after hypercapnia; n ϭ 6 or 7 per group. *P Ͻ 0.05 vs. normocapnia. C: representative brain sections from rat pups exposed for 18 h to normocapnia (control) or hypercapnia (CO2) and stained with lectin (red) and 3-nitrotyrosine antibody (green). Arrows indicate lectin and 3-nitrotyrosine colocalization. Scale bar ϭ 100 m.
actin primers according to Sullivan et al. (35) . Neuronal NOS (nNOS) primers were designed using the DNAMAN software (Lynnon) and had the following forward and reverse sequences: 5=-AAGCCGTC-GATCTGTCTCA-3= and 5=-CCACACCATTAGCTTGGGA-3=, respectively.
Western blot analysis. Standard SDS-PAGE techniques were conducted on 60 g of proteins. eNOS primary antibody (BD Biosciences) was used at a 1:1,000 dilution. Equal protein loading was ensured by probing with a beta-actin antibody (1:10 000; Santa Cruz Biothechnology). Densitometry was measured using the ImageJ 1.41 software (National Institutes of Health, Bethesda, MD).
Statistical analysis. Values are presented as means Ϯ SE. Statistical analysis were performed by one-way ANOVA, followed by Tukey's post hoc test for multiple comparisons, except for the data in Fig. 1, C and D , where a two-way ANOVA followed by Bonferronni's post hoc test was performed. For comparisons simply between two groups, Student's t-test was used. P Ͻ 0.05 was considered to denote significant differences.
RESULTS
Effects of hypercapnia on cerebral cortex vascular density and brain weight. Exposure of neonatal rat pups to hypercapnia (Pa CO 2 ϭ 60 -70 mmHg) from P1 to P7 resulted in a 20% decrease in cerebral cortex microvasculature density by P3 (Fig. 1A) , at which time (apoptotic) cell death (TUNEL positivity) was detected mostly in microvasculature and also to Fig. 4 . Effects of pharmacological treatments on hypercapnia-induced brain cortex 14E-AA levels (A), nitrative stress (B), brain cortex microvascular density (C, D), and brain weight (E). A: brain cortex 14E-AA levels determined 18 h after hypercapnia. Pups were treated or not with a nitric oxide synthase inhibitor (L-NAME; 20 mg/kg) and exposed for 18 h to hypercapnia (CO2); n ϭ 6 or 7 per group. *P Ͻ 0.05 vs. normocapnia. B: representative brain sections stained with lectin (red) and 3-nitrotyrosine antibody (green). Pups were treated or not with L-NAME (20 mg/kg) or a peroxynitrite decomposition catalyst (FeTPPS; 10 mg/kg) and exposed to hypercapnia (CO2). B: arrows indicate lectin and 3-nitrotyrosine colocalization. Scale bar ϭ 100 m. C: representative lectin-stained cerebral sections from P3 rat pups treated as in B. Scale bar ϭ 100 m. D: quantification of cerebrovascular density from rat pups treated as indicated in C. Values in histogram are expressed as means Ϯ SE of vessel density in cortical regions; n ϭ 5 or 6 per group. Scale bar ϭ 100 m. *P Ͻ 0.05 vs. normocapnia. E: brain weight assessed in P7 rat pups treated or not with L-NAME (20 mg/kg) or FeTPPS (10 mg/kg) and exposed to hypercapnia (CO2); n ϭ 10 -20 per group. *P Ͻ 0.05 vs. normocapnia. some extent on parenchyma (Fig. 1B) . By P7, microvascular density was equivalent to that in normocapnia-exposed animals, indicative of accrued revascularization following the early vasoobliteration, as reported in other conditions associated with vessel loss (34) . Nonetheless, brain mass growth remained curtailed into adolescence (P30), despite resuming normocapnia since P7 (Fig. 1C) . It is noteworthy that body weight did not change in any time points investigated (Fig. 1D) .
Effects of hypercapnia on eNOS expression and on products of nitration. Hypercapnia has been shown to increase eNOS expression in brain cortex (24) . Concordantly, eNOS (but not inducible NOS or nNOS) mRNA expression and immunoreactivity were augmented by 18 h of exposure to high CO 2 (Fig. 2,  A-C) , and this was associated with increased generation of nitrite/nitrate (oxidation products of NO) and lipid nitration product 14E-AA in the brain cortex (Fig. 3, A and B) . Immunohistochemistry also revealed that early nitration (of proteins) was foremost localized on brain microvessels (Fig. 3C) , consistent with increased susceptibility of microvessels to nitrooxidative stress (7, 34) .
Nitric oxide synthase inhibition and enhanced peroxynitrite decomposition prevent vascular degeneration and loss of brain mass. Nitric oxide synthase inhibitor L-NAME (20 mg/kg ip) decreased generation of nitration products (14E-AA and 3-nitrotyrosine) (Fig. 4, A and B) as expected, and preserved cortical vascular density, as well as brain mass (Fig. 4, C-E) ; similar benefits were observed with the peroxynitrite decomposition catalyst FeTPPS (10 mg/kg ip). It should be noted that drug treatments in normocapnia-exposed animals did not affect vascular density or brain weight (Fig. 4, D and E) .
Endothelial cytotoxicity to high CO 2 and TAA ex vivo. Chronic hypercapnia increases oxygen delivery to the brain of the newborn (24) , which, in turn, can exacerbate peroxidation and tissue injury in immature subjects. We, therefore, tested whether high CO 2 can cause endothelial cytotoxicity independent of changes in oxygen concentration. Exposure of cultured cerebral microvascular endothelial cells to 10% CO 2 diminished cell viability and vascular sprouting of aortic explants; these effects were prevented by L-NAME or FeTPPS (Fig. 5, A  and B) ; observations are consistent with increased nitration in response to high CO 2 , as previously shown ex vivo in other tissues (31) . Finally, in line with cytotoxicity of TAAs (20), 14E-AA caused within 24 h microvascular degeneration in brain explants (Fig. 5C) ; in vivo intraventricular injection of 14E-AA at physiological concentration also markedly decreased periventricular brain vascular density 24 h later (Fig. 5D ).
DISCUSSION
Hypercapnia may be beneficial for lungs of newborns (23), but neurodevelopment may be adversely affected by extremes of hypercapnia (Ͼ65 mmHg) (11, 37) . Marked and prolonged increases in cerebral circulation may explain observed brain hemorrhages (24) . However, hemorrhages do not seem to account for the majority of neurodevelopmental disorder asso- A: endothelial cell viability quantified by MTT assay. Cells were cultured for 24 h in 5% (control) or 10% CO2, with or without L-NAME (5 M) or FeTPPS (5 M); n ϭ 4 experiments each performed in triplicate; *P Ͻ 0.05. B: representative microvascular sprouting from Matrigel-embedded aortic rings cultured in 5% (control) or 10% CO2, with or without FeTPPS (5 M). Scale bar ϭ 1 mm; n ϭ 6 -9 explants per group; *P Ͻ 0.05 vs. normocapnia. Drug treatment in control explants did not affect vascular sprouting when compared with untreated explants (not shown). C: ex vivo effects of 14E-AA (5 M) on cerebral cortex vascular density of rat brain explants. Scale bar ϭ 100 m; n ϭ 4 separate experiments. *P Յ 0.05 compared with control explants. D: representative lectin-stained cerebral sections 24 h after intracerebroventricular injections of 0.5% ethanol in saline (control) or 14E-AA (10 M). Scale bar ϭ 100 m; n ϭ 4 or 5 per group. *P Ͻ 0.05 compared with control. ciated with hypercapnia (37) . In line with this inference, hypercapnia depletes the vascular bed of retina by causing microvascular dropout (7) . The current study expands on this notion by showing that clinically observed chronic hypercapnia (Pa CO 2 Ϸ 65 mmHg) causes cerebral vasoobliteration in the developing subject, by inducing nitrative stress; inhibition of the nitrative stress preserves brain microvasculature and mass.
Our observations point to an important role for the NOS pathway and reactive NO products in cerebral cortical microvascular degeneration upon exposure to hypercapnia. The expression particularly of eNOS was found to augment by 18 h in response to hypercapnia (Fig. 2, A-C) , as previously demonstrated (24) . The ensued rise in NO can exert either protective or cytotoxic effects, depending on local tissue redox potential (2); accordingly, excessive NO production in the presence of incompletely developed antioxidant systems, as seen in the immature subject, leads to generation of reactive nitrogen species, which can cause endothelial cell injury (2), as evidenced herein (Figs. 3 and 4) . Along these lines, CO 2 enhances nitration by interacting with peroxynitrite to form a more unstable and efficient nitrating adduct nitrosoperoxocarbonate (14) , which shifts peroxynitrite from forming reactive oxygen species to reactive nitrogen species (3) . This nitrative capacity is clearly exemplified in vitro by the fact that peroxynitrite in combination with increased CO 2 levels enhances protein nitration (31) . We, hereby, demonstrate in vivo in brain that hypercapnia not only increases generation of nitrates but also of protein and lipid nitration products (Fig. 3) .
Neurovascular endothelial cells are particularly susceptible to nitrative stress (1, 15, 20, 34) , more so than glia (4) . In line with this claim, early detection (18 h) of nitrotyrosine was largely confined to the microvasculature (Fig. 3C ) and preceded vasoobliteration (Fig. 1A) . More relevantly, products of nitration (3-nitrotyrosine and TAA), as well as vessel loss, were decreased by NOS inhibition and catalyst of peroxynitrite decomposition (Fig. 4) . In addition, microvascular endothelial cytotoxicity to the nitration product TAA (20) was reproduced on brain explants and in vivo (Fig. 5, C and D) . Vulnerability of the endothelium to nitration product TAA has been attributed to the formation of the proapoptotic antiangiogenic thrombospondin-1 (20) . Correspondingly, we detected an increased expression of thrombospondin-1 in the brain of hypercapniaexposed rats, which was prevented by pretreatment with FeTPPS (data not shown).
Rat pups provide an interesting model to study brain development occurring in preterm neonates since neuronal generation is complete and axonal and dendritic branching is robust, corresponding to the development observed in preterm infants at the second trimester of gestation (10, 12) . Interestingly, neuronal metabolism and the peak of angiogenic activity during vascular development coincides (29) . In cortical areas of rat pups, vascular development continuously occurs from P3 to P24, then stabilizing between P24 and P33 (26) . Upon prolonged hypercapnic exposure, alteration of the cortical cerebrovascular density as evidenced in the current study (Fig. 1A) impairs neurovascular metabolism and neuronal development, leading to the brain growth retardation observed at P7 (Fig.  1C) . In line with this hypothesis, formation and sprouting of blood vessels are very important for brain maturation (27) . Importantly, and despite the observed revascularization phase (Fig. 1A) , brain retardation remains in P30 rat pups (Fig. 1C) ; this suggests that early alteration of angiogenesis induced by sustained hypercapnia, as encountered in uncured BPD patients, may curtail growth of the rapidly developing cortex of fetus and premature infants (30) .
In conclusion, we, hereby, show that clinically relevant prolonged hypercapnia causes brain microvascular degeneration by generating a nitrative stress triggered likely by eNOS. Despite an accelerated revascularization and resulting normalization of the vascular density following the cerebral vasoobliteration, brain mass growth remained curtailed well after the insult.
Perspectives and Significance
The cerebral endothelial cytotoxicity to sustained high blood CO 2 observed in this study may have broader implications than simply those presented. Ischemia per se results in local elevation in CO 2 (18, 38) . Despite the fact that a transient increase in CO 2 may preserve cerebral blood flow after hypoxia/ischemia (21) , one can surmise that the sustained accumulation of CO 2 in ischemic brain tissue may partake in intensifying neuromicrovascular degeneration. As such, achievable preventative measures are foreseeable. Modulation of NO formation may prove difficult because of the benefits incurred to the vasculature by this mediator. However, inhibition of nitrative stress carries greater potential, as it could specifically improve revascularization and assist in preserving organ integrity following detrimental factors commonly encountered by the preterm infant, specifically not only the well-described hyperoxia (34) , ischemia, and possibly hypocapnia (8, 32) , but also hypercapnia as described herein. 
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